United States · 
Who invested in TORL BioTherapeutics?
TORL BioTherapeutics's investors include RA Capital Management, Perceptive Advisors, Deep Track Capital, Goldman Sachs and Vertex Ventures, and 2 more on record.
2025
$158MSeries B$96MSeries CUnited States · Series C startup
Who invested in TORL BioTherapeutics
2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$254Mraised across 2 rounds since 2024, from 2 sources
$158MSeries B$96MSeries C
- Latest round
- Series C, $96MOct 2025
- Biggest round
- $158MSeries B · Apr 2024
- Investors
- 7 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $158M Apr 2024
- Biggest round
- $158M Series B · Apr 2024
- Between rounds
- 18 months from the last two
The rounds
- Oct 2025Series C$96M3 new2 returning
Source recorded
- Apr 2024Series B$158M4 new
Reported by OCVSEC filing: $158M sold, first sale Apr 2024
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about TORL BioTherapeutics
How much has TORL BioTherapeutics raised?
TORL BioTherapeutics has raised $254M across 2 rounds since 2024.
When did TORL BioTherapeutics last raise?
TORL BioTherapeutics's most recent round was a Series C of $96M in Oct 2025.
What was TORL BioTherapeutics's biggest round?
TORL BioTherapeutics's largest round on record is $158M (Series B), in Apr 2024, led by Deep Track Capital.
Who backed TORL BioTherapeutics first?
TORL BioTherapeutics's first round on record, in Apr 2024, was backed by Deep Track Capital, RA Capital Management and Perceptive Advisors and 1 others.
What stage is TORL BioTherapeutics at?
TORL BioTherapeutics's latest named round is a Series C, in Oct 2025.
Where is TORL BioTherapeutics based?
TORL BioTherapeutics is based in the United States.
Who led TORL BioTherapeutics's rounds?
Deep Track Capital led the Series B in 2024.
Companies like TORL BioTherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.